Eric Mortensen will become Cytosorbents Corp.'s chief medical officer on June 1, succeeding Robert Bartlett, who is retiring.

Bartlett will continue working with the company as a consultant and as co-chair of the cardiac surgery advisory board with Joseph Zwischenberger.

Mortensen is the former vice president and therapeutic area clinical head for inflammation and immunology at Pfizer Inc.